Yixintang Pharmaceutical Group Co., Ltd. (002727) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Yixintang Pharmaceutical Group Co., Ltd.

Why is Yixintang Pharmaceutical Group Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 8.98% and Operating profit at -18.37% over the last 5 years

The company has declared Negative results for the last 7 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at CNY 1,697.68 MM
ROCE(HY) Lowest at 0.42%
INTEREST COVERAGE RATIO(Q) Lowest at 619.66

With ROE of 1.38%, it has a very attractive valuation with a 0.77 Price to Book Value

Over the past year, while the stock has generated a return of -9.22%, its profits have fallen by -72%
At the current price, the company has a high dividend yield of 3.1

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -9.22% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Yixintang Pharmaceutical Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Retailing should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Yixintang Pharmaceutical Group Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Yixintang Pharmaceutical Group Co., Ltd.

-7.78%

-0.65

35.54%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

8.98%

EBIT Growth (5y)

-18.37%

EBIT to Interest (avg)

9.22

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

1.63

Tax Ratio

70.33%

Dividend Payout Ratio

155.68%

Pledged Shares

Institutional Holding

ROCE (avg)

12.89%

ROE (avg)

9.80%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.77

EV to EBIT

21.02

EV to EBITDA

3.36

EV to Capital Employed

0.78

EV to Sales

0.34

PEG Ratio

Dividend Yield

3.11%

ROCE (Latest)

3.72%

ROE (Latest)

1.38%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -7.22% (YoY

-21What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 1,697.68 MM

ROCE(HY)

Lowest at 0.42%

INTEREST COVERAGE RATIO(Q)

Lowest at 619.66

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.05%

DEBTORS TURNOVER RATIO(HY)

Lowest at 7.54%

OPERATING PROFIT(Q)

Lowest at CNY 212.14 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 4.46 %

PRE-TAX PROFIT(Q)

Fallen at -28.16%

NET PROFIT(Q)

Fallen at -33.83%

Here's what is working for Yixintang Pharmaceutical Group Co., Ltd.

Raw Material Cost

Fallen by -7.22% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Yixintang Pharmaceutical Group Co., Ltd.

Operating Cash Flow

Lowest at CNY 1,697.68 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest Coverage Ratio

Lowest at 619.66

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 212.14 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 4.46 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Fallen at -28.16%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Fallen at -33.83%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 3.05%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 7.54%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio